TAK1 Suppresses a NEMO-Dependent but NF-κB-Independent Pathway to Liver Cancer

Cancer Cell

Volumn 17, Issue 5, 2010, Pages 481-496

  Bettermann, Kira ^a   Vucur, Mihael ^a   Haybaeck, Johannes ^b   Koppe, Christiane ^a   Janssen, Jörn ^a   Heymann, Felix ^a   Weber, Achim ^b   Weiskirchen, Ralf ^a   Liedtke, Christian ^a   Gassler, Nikolaus ^a   Müller, Michael ^c   de Vos, Rita ^d   Wolf, Monika Julia ^b   Boege, Yannick ^b   Seleznik, Gitta Maria ^b   Zeller, Nicolas ^e   Erny, Daniel ^e   Fuchs, Thomas ^f   Zoller, Stefan ^g   Cairo, Stefano ^h   Buendia, Marie Annick ^h   Prinz, Marco ^e   Akira, Shizuo ⁱ   Tacke, Frank ^a   Heikenwalder, Mathias ^b   Trautwein, Christian ^a   Luedde, Tom ^a   more..

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e UNIVERSITY OF FREIBURG   (Germany)

^f ETH ZURICH   (Switzerland)

^g FUNCTIONAL GENOMICS CENTER ZURICH   (Switzerland)

^h INSTITUT PASTEUR   (France)

ⁱ OSAKA UNIVERSITY   (Japan)

Author keywords

CELLCYCLE

Indexed keywords

CASPASE 3; I KAPPA B KINASE; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BILE DUCT; CANCER INHIBITION; CHOLESTASIS; CONTROLLED STUDY; DYSPLASIA; ENZYME ACTIVITY; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL; LIVER PARENCHYMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

PYRONIA TITHONUS;

EID: 77952107213     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2010.03.021     Document Type: Article

References (36)

1. Adhikari A., Xu M., and Chen Z.J. Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 26 (2007) 3214-3226
2. Ariel I., Miao H.Q., Ji X.R., Schneider T., Roll D., de Groot N., Hochberg A., and Ayesh S. Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma. Mol. Pathol. 51 (1998) 21-25
3. Bataller R., and Brenner D.A. Liver fibrosis. J. Clin. Invest. 115 (2005) 209-218
4. Ben Moshe T., Barash H., Kang T.B., Kim J.C., Kovalenko A., Gross E., Schuchmann M., Abramovitch R., Galun E., and Wallach D. Role of caspase-8 in hepatocyte response to infection and injury in mice. Hepatology 45 (2007) 1014-1024
5. Beraza N., Malato Y., Sander L.E., Al-Masaoudi M., Freimuth J., Riethmacher D., Gores G.J., Roskams T., Liedtke C., and Trautwein C. Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage. J. Exp. Med. 206 (2009) 1727-1737
6. Cairo S., Armengol C., De Reynies A., Wei Y., Thomas E., Renard C.A., Goga A., Balakrishnan A., Semeraro M., Gresh L., et al. Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell 14 (2008) 471-484
7. Chariot A. The NF-kappaB-independent functions of IKK subunits in immunity and cancer. Trends Cell Biol. 19 (2009) 404-413
8. Chen Z., Raman M., Chen L., Lee S.F., Gilman A.G., and Cobb M.H. TAO (thousand-and-one amino acid) protein kinases mediate signaling from carbachol to p38 mitogen-activated protein kinase and ternary complex factors. J. Biol. Chem. 278 (2003) 22278-22283
9. Cho Y.S., Challa S., Moquin D., Genga R., Ray T.D., Guildford M., and Chan F.K. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137 (2009) 1112-1123
10. Enomoto N., Takei Y., Hirose M., Ikejima K., Miwa H., Kitamura T., and Sato N. Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-alpha production. Gastroenterology 123 (2002) 291-300
11. Essers M.A., Weijzen S., de Vries-Smits A.M., Saarloos I., de Ruiter N.D., Bos J.L., and Burgering B.M. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 23 (2004) 4802-4812
12. Hacker H., and Karin M. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006 (2006) re13
13. Haybaeck J., Zeller N., Wolf M.J., Weber A., Wagner U., Kurrer M.O., Bremer J., Iezzi G., Graf R., Clavien P.A., et al. A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell 16 (2009) 295-308
14. Hu M.C., Lee D.F., Xia W., Golfman L.S., Ou-Yang F., Yang J.Y., Zou Y., Bao S., Hanada N., Saso H., et al. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117 (2004) 225-237
15. Inokuchi S., Aoyama T., Miura K., Osterreicher C.H., Kodama Y., Miyai K., Akira S., Brenner D.A., and Seki E. Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis. Proc. Natl. Acad. Sci. USA 107 (2010) 844-849
16. Irelan J.T., Murphy T.J., DeJesus P.D., Teo H., Xu D., Gomez-Ferreria M.A., Zhou Y., Miraglia L.J., Rines D.R., Verma I.M., et al. A role for IkappaB kinase 2 in bipolar spindle assembly. Proc. Natl. Acad. Sci. USA 104 (2007) 16940-16945
17. Kamata H., Honda S., Maeda S., Chang L., Hirata H., and Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120 (2005) 649-661
18. Karin M., and Gallagher E. TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexes. Immunol. Rev. 228 (2009) 225-240
19. Kellendonk C., Opherk C., Anlag K., Schutz G., and Tronche F. Hepatocyte-specific expression of Cre recombinase. Genesis 26 (2000) 151-153
20. Kim S., Kim Y., Lee J., and Chung J. Regulation of FOXO1 by TAK1-NLK pathway. J. Biol. Chem. 285 (2010) 8122-8129
21. Leist M., Gantner F., Bohlinger I., Tiegs G., Germann P.G., and Wendel A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am. J. Pathol. 146 (1995) 1220-1234
22. Luedde T., Beraza N., Kotsikoris V., van Loo G., Nenci A., De Vos R., Roskams T., Trautwein C., and Pasparakis M. Deletion of NEMO/IKKgamma in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma. Cancer Cell 11 (2007) 119-132
23. Luedde T., Heinrichsdorff J., De Lorenzi R., De Vos R., Roskams T., and Pasparakis M. IKK1 and IKK2 cooperate to maintain bile duct integrity in the liver. Proc. Natl. Acad. Sci. USA 105 (2008) 9733-9738
24. Maeda S., Kamata H., Luo J.L., Leffert H., and Karin M. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121 (2005) 977-990
25. Okuda K. Hepatocellular carcinoma. J. Hepatol. 32 (2000) 225-237
26. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., Urieli-Shoval S., Galun E., and Ben Neriah Y. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431 (2004) 461-466
27. Postic C., and Magnuson M.A. DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 26 (2000) 149-150
28. Renard C.A., Fourel G., Bralet M.P., Degott C., De La Coste A., Perret C., Tiollais P., and Buendia M.A. Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles. Oncogene 19 (2000) 2678-2686
29. Rincon M., and Davis R.J. Regulation of the immune response by stress-activated protein kinases. Immunol. Rev. 228 (2009) 212-224
30. Sakurai T., Maeda S., Chang L., and Karin M. Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proc. Natl. Acad. Sci. USA 103 (2006) 10544-10551
31. Sato S., Sanjo H., Takeda K., Ninomiya-Tsuji J., Yamamoto M., Kawai T., Matsumoto K., Takeuchi O., and Akira S. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6 (2005) 1087-1095
32. Tang M., Wei X., Guo Y., Breslin P., Zhang S., Wei W., Xia Z., Diaz M., Akira S., and Zhang J. TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice. J. Exp. Med. 205 (2008) 1611-1619
33. Vainer G.W., Pikarsky E., and Ben-Neriah Y. Contradictory functions of NF-kappaB in liver physiology and cancer. Cancer Lett. 267 (2008) 182-188
34. Wagner E.F., and Nebreda A.R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9 (2009) 537-549
35. Wan Y.Y., Chi H., Xie M., Schneider M.D., and Flavell R.A. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat. Immunol. 7 (2006) 851-858
36. Xu X., Kobayashi S., Qiao W., Li C., Xiao C., Radaeva S., Stiles B., Wang R.H., Ohara N., Yoshino T., et al. Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice. J. Clin. Invest. 116 (2006) 1843-1852